Latest Regulatory Approval News

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.

Rio Tinto's Q4 2024 production results reflect steady operational performance with record bauxite output and significant progress on key growth projects like Oyu Tolgoi and Rincon lithium expansion.

Magnetic Resources has significantly increased the gold resource estimate at its Lady Julie Gold Project to 1.75 million ounces, advancing plans for concurrent underground mining and an expanded processing plant.

BPM Minerals reports significant progress at its Claw Gold Project, completing a third drilling phase and preparing for expanded exploration across new tenements. The company maintains a strong cash position to support its growth ambitions.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Latitude Group Holdings Limited has revised its distribution on Capital Notes from AUD 1.6136 to AUD 2.3052, reflecting a shift to a 0% franked component and the introduction of conduit foreign income.

Echelon Resources has agreed to acquire full ownership and operatorship of the EP145 exploration permit in the Northern Territory’s Amadeus Basin, aiming to unlock a discovered gas resource with modern technology.

Peninsula Energy has resumed uranium production at its Lance Project in Wyoming, capturing 1,100 pounds of uranium in late December 2024, while securing key regulatory approvals to expand mining operations.

Amcor plc and Berry Global Group, Inc. have entered into a definitive merger agreement for an all-stock transaction valued at approximately $9.9 billion. The combined entity aims to leverage significant synergies and enhanced market reach, pending shareholder and regulatory approvals.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

4DMedical has landed a paid pilot contract with the US Department of Defense to deploy its CT:VQ™ lung imaging technology on active-duty personnel, marking a significant step before FDA submission and spotlighting a billion-dollar market opportunity.